Subtopic Deep Dive

NF-κB Activation in Inflammation
Research Guide

What is NF-κB Activation in Inflammation?

NF-κB activation in inflammation refers to the IKK complex-mediated nuclear translocation of NF-κB dimers triggered by pathogens and cytokines via canonical and non-canonical pathways.

This process drives expression of pro-inflammatory genes like cytokines and adhesion molecules. Canonical pathway involves IKKβ phosphorylation of IκBα for degradation, while non-canonical uses NIK-IKKα for p100 processing. Over 10 papers from the list examine its role in diseases including cancer and airway inflammation.

15
Curated Papers
3
Key Challenges

Why It Matters

NF-κB activation sustains chronic inflammation in arthritis, asthma, COPD, and cancer, promoting tumor progression and metastasis (Maeda and Omata, 2008; 228 citations). In airway diseases, it links oxidative stress to pharmacological resistance in asthma and COPD (Schuliga, 2015; 405 citations). Therapeutic inhibitors targeting IKK or NF-κB nuclear entry show promise in preclinical models of lung injury and liver carcinogenesis (Németh et al., 2009; 173 citations).

Key Research Challenges

Pathway Crosstalk Complexity

Canonical and non-canonical NF-κB pathways interact with MAPK and ROS signaling, complicating targeted inhibition (Maeda and Omata, 2008). Oxidative stress in COPD amplifies NF-κB via TLR4, overlapping with metabolic inflammation (Schuliga, 2015; Sindhu et al., 2018).

Tissue-Specific Regulation

NF-κB targets vary by cell type, driving carcinogenesis in liver but immunomodulation in airways (Németh et al., 2009). Astrocyte swelling in neuroinflammation shows cytokine-potentiated NF-κB effects unique to CNS (Rama Rao et al., 2010).

Inhibitor Selectivity Issues

Broad NF-κB blockade risks immunosuppression, as seen in MALT1 deficiency causing combined immunodeficiency (McKinnon et al., 2013; 115 citations). Natural compounds like cyanidin suppress NF-κB but require pathway-specific validation (Ma et al., 2015).

Essential Papers

1.

NF-kappaB Signaling in Chronic Inflammatory Airway Disease

Michael Schuliga · 2015 · Biomolecules · 405 citations

Asthma and chronic obstructive pulmonary disease (COPD) are obstructive airway disorders which differ in their underlying causes and phenotypes but overlap in patterns of pharmacological treatments...

2.

Inflammation and cancer: Role of nuclear factor‐kappaB activation

Shin Maeda, Masao Omata · 2008 · Cancer Science · 228 citations

It has been thought that there is a strong relationship between inflammation and carcinogenesis so that the development of cancer occurs with chronic inflammation in many organs. An in‐depth unders...

3.

S100A8 and S100A9 Are Novel Nuclear Factor Kappa B Target Genes During Malignant Progression of Murine and Human Liver Carcinogenesis†

Júlia Németh, Ilan Stein, Daniel Haag et al. · 2009 · Hepatology · 173 citations

The nuclear factor-kappaB (NF-κB) signaling pathway has been recently shown to participate in inflammation-induced cancer progression. Here, we describe a detailed analysis of the NF-κB–dependent g...

4.

Combined immunodeficiency associated with homozygous MALT1 mutations

Margaret L. McKinnon, Jacob Rozmus, Shan‐Yu Fung et al. · 2013 · Journal of Allergy and Clinical Immunology · 115 citations

5.

Marked potentiation of cell swelling by cytokines in ammonia-sensitized cultured astrocytes

Kakulavarapu V. Rama Rao, Arumugam R. Jayakumar, Xiaoying Tong et al. · 2010 · Journal of Neuroinflammation · 96 citations

6.

Increased Expression of the Innate Immune Receptor TLR10 in Obesity and Type-2 Diabetes: Association with ROS-Mediated Oxidative Stress

Sardar Sindhu, Nadeem Akhter, Shihab Kochumon et al. · 2018 · Cellular Physiology and Biochemistry · 68 citations

Background/Aims: Metabolic diseases such as obesity and type-2 diabetes (T2D) are known to be associated with chronic low-grade inflammation called metabolic inflammation together with an oxidative...

Reading Guide

Foundational Papers

Start with Maeda and Omata (2008; 228 citations) for inflammation-cancer links, then Németh et al. (2009; 173 citations) for NF-κB gene networks in vivo, and McKinnon et al. (2013; 115 citations) for pathway deficiencies.

Recent Advances

Schuliga (2015; 405 citations) for airway applications; Sindhu et al. (2018; 68 citations) for TLR10 in metabolic inflammation; Ma et al. (2015; 67 citations) for NF-κB inhibitors.

Core Methods

LPS/cytokine stimulation, IKK knockout models, ChIP for nuclear translocation, qPCR for targets like S100A8/A9, immunohistochemistry in disease tissues.

How PapersFlow Helps You Research NF-κB Activation in Inflammation

Discover & Search

Research Agent uses searchPapers and exaSearch to find NF-κB papers by querying 'IKK NF-κB inflammation canonical pathway', then citationGraph on Schuliga (2015; 405 citations) reveals high-impact airway disease clusters. findSimilarPapers expands to COPD-asthma overlaps.

Analyze & Verify

Analysis Agent applies readPaperContent to extract IKK mechanisms from Maeda and Omata (2008), then verifyResponse with CoVe checks claims against Németh et al. (2009). runPythonAnalysis with pandas quantifies citation overlaps; GRADE scores evidence strength for therapeutic targeting.

Synthesize & Write

Synthesis Agent detects gaps in non-canonical pathway inhibitors via contradiction flagging across papers. Writing Agent uses latexEditText for pathway diagrams, latexSyncCitations for 10+ references, and latexCompile to generate review sections with exportMermaid for NF-κB signaling flowcharts.

Use Cases

"Extract NF-κB target gene expression data from liver cancer inflammation papers and plot citation trends."

Research Agent → searchPapers('S100A8 NF-κB liver') → Analysis Agent → readPaperContent(Németh 2009) → runPythonAnalysis(pandas/matplotlib on gene lists and citations) → CSV export of quantified targets.

"Draft LaTeX figure of canonical vs non-canonical NF-κB pathways with citations from top papers."

Synthesis Agent → gap detection → Writing Agent → latexGenerateFigure('NF-κB pathways') → latexSyncCitations(Schuliga 2015, Maeda 2008) → latexCompile → PDF with diagram.

"Find GitHub repos analyzing NF-κB inhibitor simulations from inflammation papers."

Research Agent → paperExtractUrls(Ma 2015 cyanidin) → paperFindGithubRepo → Code Discovery → githubRepoInspect → Verified code for MAPK-NF-κB models.

Automated Workflows

Deep Research workflow scans 50+ NF-κB inflammation papers via searchPapers → citationGraph → structured report with GRADE-scored pathways. DeepScan applies 7-step CoVe to verify IKK inhibitor efficacy across Schuliga (2015) and Maeda (2008). Theorizer generates hypotheses on ROS-TLR4-NF-κB links from Sindhu et al. (2018).

Frequently Asked Questions

What defines NF-κB activation in inflammation?

IKK complex phosphorylates IκB, enabling NF-κB nuclear translocation to transcribe pro-inflammatory genes in response to cytokines and pathogens.

What are key methods studying NF-κB pathways?

Papers use genetic models like Mdr2-/- mice for liver NF-κB targets (Németh et al., 2009), LPS stimulation for pulmonary assays (Zhong et al., 2014), and MALT1 mutations for immunodeficiency links (McKinnon et al., 2013).

What are top papers on this topic?

Schuliga (2015; 405 citations) on airway disease; Maeda and Omata (2008; 228 citations) on cancer; Németh et al. (2009; 173 citations) on liver carcinogenesis targets.

What open problems exist?

Developing selective IKK inhibitors without immunosuppression; resolving tissue-specific NF-κB targets; validating natural suppressants like cyanidin in vivo (Ma et al., 2015).

Research Immune Response and Inflammation with AI

PapersFlow provides specialized AI tools for your field researchers. Here are the most relevant for this topic:

Start Researching NF-κB Activation in Inflammation with AI

Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.